NCT02784457View on ClinicalTrials.gov

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

March 31, 2016

Conditions
Assisted Reproduction
Interventions
DRUG

Cetrorelix

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02784457 - Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome | Biotech Hunter | Biotech Hunter